HomeOCX • NASDAQ
OncoCyte Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.14M | 1,114.77% |
Operating expense | 7.17M | 22.48% |
Net income | -6.67M | 26.93% |
Net profit margin | -312.02 | 93.98% |
Earnings per share | -0.23 | 67.02% |
EBITDA | -5.35M | 1.93% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.03M | 456.27% |
Total assets | 60.36M | -14.95% |
Total liabilities | 50.14M | -7.24% |
Total equity | 10.22M | — |
Shares outstanding | 28.60M | — |
Price to book | 8.25 | — |
Return on assets | -30.58% | — |
Return on capital | -573.83% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.67M | 26.93% |
Cash from operations | -5.86M | -52.95% |
Cash from investing | -307.00K | -1,179.17% |
Cash from financing | 28.56M | — |
Net change in cash | 22.39M | 681.03% |
Free cash flow | -2.81M | -79.42% |
Previous close
$2.97
Day range
$2.84 - $3.03
Year range
$1.92 - $4.75
Market cap
84.94M USD
Avg Volume
44.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
48
